Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02878785
Title Decitabine and Talazoparib in Untreated AML and R/R AML (1565GCC)
Acronym 1565GCC
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Maryland
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field